Content about New Brunswick, New Jersey

NEW BRUNSWICK, N.J. — Johnson & Johnson has announced that Alex Gorsky will assume, effective Dec. 28, the chairman title and additional leadership responsibilities for the global health care company. 

Gorsky was appointed CEO of Johnson & Johnson in April 2012. Current chairman Bill Weldon will step down on Dec. 28 and plans to retire in the first quarter of 2013, after a brief transitional period.

NEW BRUNSWICK, N.J. — Johnson & Johnson is preparing to turn the corner with its McNeil Consumer Healthcare business, J&J chairman and CEO William Weldon told analysts during the company's fourth-quarter earnings call Tuesday. That over-the-counter business generated $5.2 billion in the United States for the year ended Jan. 2, representing a 6.7% decline as compared to 2010.

NEW BRUNSWICK, N.J. — Johnson & Johnson on Wednesday announced that Alex Gorsky, currently worldwide chairman of medical devices and diagnostics, and Sheri McCoy, currently worldwide chairman of pharmaceuticals, have been appointed vice chairmen of the executive committee, joining William Weldon, J&J chairman and CEO, in an expanded Office of the Chairman.

Both appointments are effective Jan. 3.

WASHINGTON House Committee on Oversight and Government Reform chairman Ed Towns, D-N.Y., on Thursday announced that the committee will hold a hearing Sept. 30 at 10 a.m. to examine the circumstances surrounding Johnson & Johnson’s recall of more than 135 million bottles of infant and children’s medicines produced by Johnson & Johnson/McNeil Consumer Healthcare, including children’s Tylenol, infant’s Tylenol, children’s Motrin and children’s Benadryl.